FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Viral Hepatitis

Drugs mentioned

• Epivir (Lamivudine)

Snippet

SUPPL AP for EPIVIR (LAMIVUDINE)